1. Sulfadiazine desensitisation not recommended in AIDS

   Newsletter Article 29 January 2013 Pages: 1 - 1

2. Salt substitutes have their risks

   Newsletter Article 29 January 2013 Pages: 1 - 1

3. Beware of herbal medicines

   Newsletter Article 29 January 2013 Pages: 1 - 1

4. NSAID-induced GI disorder risk: a meaningful advance

   Newsletter Article 29 January 2013 Pages: 2 - 2

5. Improve antitubercular hepatotoxicity awareness to prevent deaths

   Newsletter Article 29 January 2013 Pages: 2 - 3

6. Recommendations for formulary local anaesthetic selection

   Newsletter Article 29 January 2013 Pages: 3 - 3

7. Australian radiologists prefer low osmolar contrast media

   Newsletter Article 29 January 2013 Pages: 3 - 3

8. Drug interactions with antacids

   Newsletter Article 29 January 2013 Pages: 3 - 4

9. ACE inhibitors

   Newsletter Article 29 January 2013 Pages: 4 - 4

10. Alteplase

    Newsletter Article 29 January 2013 Pages: 4 - 4

11. Amiodarone

    Newsletter Article 29 January 2013 Pages: 4 - 4

12. Amrinone

    Newsletter Article 29 January 2013 Pages: 4 - 5

13. Antineoplastics

    Newsletter Article 29 January 2013 Pages: 5 - 5

14. Apomorphine

    Newsletter Article 29 January 2013 Pages: 5 - 5

15. Bupivacaine

    Newsletter Article 29 January 2013 Pages: 5 - 5

16. Captopril

    Newsletter Article 29 January 2013 Pages: 5 - 5

17. Carbamazepine overdose

    Newsletter Article 29 January 2013 Pages: 5 - 5

18. Carbimazole

    Newsletter Article 29 January 2013 Pages: 6 - 6

19. Cefalexin

    Newsletter Article 29 January 2013 Pages: 6 - 6

20. Ceftriaxone

    Newsletter Article 29 January 2013 Pages: 6 - 6

21. Ciprofloxacin

    Newsletter Article 29 January 2013 Pages: 6 - 6

22. Clozapine

    Newsletter Article 29 January 2013 Pages: 6 - 6

23. Contrast media

    Newsletter Article 29 January 2013 Pages: 6 - 7

24. Cotrimoxazole

    Newsletter Article 29 January 2013 Pages: 7 - 7

25. Cyclosporin

    Newsletter Article 29 January 2013 Pages: 7 - 7

26. Dextropropoxyphene

    Newsletter Article 29 January 2013 Pages: 7 - 7

27. Dihydroergotamine mesylate

    Newsletter Article 29 January 2013 Pages: 7 - 7

28. Dimenhydrinate

    Newsletter Article 29 January 2013 Pages: 7 - 8

29. Erythromycin

    Newsletter Article 29 January 2013 Pages: 8 - 8

30. Fluoxetine

    Newsletter Article 29 January 2013 Pages: 8 - 8

31. Gentamicin

    Newsletter Article 29 January 2013 Pages: 8 - 8

32. Heparin

    Newsletter Article 29 January 2013 Pages: 8 - 8

33. Interferon alpha 2B

    Newsletter Article 29 January 2013 Pages: 8 - 8

34. Interleukin 2

    Newsletter Article 29 January 2013 Pages: 8 - 8

35. Ketoprofen

    Newsletter Article 29 January 2013 Pages: 8 - 9

36. Labetalol overdose

    Newsletter Article 29 January 2013 Pages: 9 - 9

37. Levodopa

    Newsletter Article 29 January 2013 Pages: 9 - 9

38. Lisinopril

    Newsletter Article 29 January 2013 Pages: 9 - 9

39. Lithium

    Newsletter Article 29 January 2013 Pages: 9 - 9

40. Lorazepam

    Newsletter Article 29 January 2013 Pages: 9 - 9

41. Misoprostol see Phenylbutazone interaction

    Newsletter Article 29 January 2013 Pages: 9 - 9

42. Mitomycin

    Newsletter Article 29 January 2013 Pages: 9 - 9

43. Morphine

    Newsletter Article 29 January 2013 Pages: 9 - 10

44. Muromonab CD3

    Newsletter Article 29 January 2013 Pages: 10 - 10

45. Nifedipine

    Newsletter Article 29 January 2013 Pages: 10 - 10

46. Nilutamide

    Newsletter Article 29 January 2013 Pages: 10 - 10

47. NSAIDs

    Newsletter Article 29 January 2013 Pages: 10 - 10

48. Ofloxacin

    Newsletter Article 29 January 2013 Pages: 10 - 10

49. Pethidine

    Newsletter Article 29 January 2013 Pages: 10 - 11

50. Phenylbutazone interaction

    Newsletter Article 29 January 2013 Pages: 11 - 11